Sophie Shen
About Sophie Shen
Sophie Shen is the Director of Pharmacoepidemiology at Bristol Myers Squibb, with over a decade of experience in epidemiology and health economics within the company.
Current Position at Bristol Myers Squibb
Sophie Shen is currently serving as the Director of Pharmacoepidemiology at Bristol Myers Squibb in Princeton, New Jersey. In this role, she leads the company's cardiovascular epidemiology initiatives, leveraging her extensive experience in the field to drive critical research efforts.
Professional Journey at Bristol Myers Squibb
Sophie Shen has dedicated over a decade to Bristol Myers Squibb, holding various roles that have progressively increased in responsibility. She began her tenure in 2007 as an Outcomes Research Scientist in Global Health Economics and Outcomes Research. Over the years, she transitioned to focus more on epidemiology, moving through positions as Manager, Senior Manager, Associate Director, and now as Director of Pharmacoepidemiology.
Experience in Epidemiology
Sophie Shen's career at Bristol Myers Squibb is marked by a significant focus on epidemiology. She initially served as Manager and Senior Manager of Epidemiology in Hopewell, New Jersey. Later, she continued her contributions to the field by becoming Associate Director of Pharmacoepidemiology and ultimately advancing to her current directorial role.
Educational Background
Sophie Shen is an alumna of Villanova University and the University of Medicine and Dentistry of New Jersey. Her academic background has provided a strong foundation for her extensive work in pharmacoepidemiology and health economics at Bristol Myers Squibb.
Career Transition and Growth
Sophie Shen has shown notable career growth within Bristol Myers Squibb, transitioning from Global Health Economics and Outcomes Research to a specialized focus on epidemiology. Her journey within the company reflects a solid commitment to enhancing health outcomes through rigorous epidemiological research and leadership.